is a senior correspondent and author of Notepad , who has been covering all things Microsoft, PC, and tech for over 20 years. Posts from this author will be added to your daily email digest and your homepage feed. Nvidia announced more than two years ago that it was working to replace its Control Panel app on Windows with a new Nvidia app. After porting across various features to the Nvidia app, N...
is a senior correspondent and author of Notepad , who has been covering all things Microsoft, PC, and tech for over 20 years. Posts from this author will be added to your daily email digest and your homepage feed. Nvidia announced more than two years ago that it was working to replace its Control Panel app on Windows with a new Nvidia app. After porting across various features to the Nvidia app, Nvidia is announcing today that it has officially retired the Control Panel app. “With the introduction of our most recent Nvidia App update, all actively supported Nvidia Control Panel features for GeForce users have been modernized and transitioned to the new client,” says Nvidia. “After 20 years of dedicated service, the classic Nvidia Control Panel is officially retiring for Game Ready and Studio Drivers. For Nvidia RTX PRO users, the Nvidia Control Panel will continue to be supported until we have migrated professional features to the Nvidia app.” Nvidia’s legacy Control Panel app will remain installed on people’s PCs unless a driver clean install is completed. Even so, if you do need the Control Panel app it will remain in the Microsoft Store, but it won’t be getting any new features or fixes. Nvidia ported across the majority of important Control Panel features to the Nvidia app last year, and it has become an all-in-one app that can download and install drivers, manage game settings, and toggle different DLSS modes. Nvidia also released a new Game Ready driver today, optimized just in time for the launch of 007 First Light. The latest 610.47 driver also includes support for Lego Batman: Legacy of the Dark Knight.
Shares of Advanced Micro Devices (NASDAQ:AMD) are up 5% in early Tuesday trading, leading a broad lift across the chip complex. Intel (NASDAQ:INTC) is up 2%, while NVIDIA (NASDAQ:NVDA) is essentially flat. The move follows a price target bombshell from UBS on Micron Technology (NASDAQ:MU) this morning. UBS raised its Micron target to $1,625 from ... AMD Is Up 5% Today: Is It Outperforming Other Ch...
Shares of Advanced Micro Devices (NASDAQ:AMD) are up 5% in early Tuesday trading, leading a broad lift across the chip complex. Intel (NASDAQ:INTC) is up 2%, while NVIDIA (NASDAQ:NVDA) is essentially flat. The move follows a price target bombshell from UBS on Micron Technology (NASDAQ:MU) this morning. UBS raised its Micron target to $1,625 from ... AMD Is Up 5% Today: Is It Outperforming Other Chip Stocks Like Intel and NVIDIA?
Quick Read Advanced Micro Devices (AMD) stock rose 5% today, outperforming Intel (INTC) at +2% and NVIDIA (NVDA) at breakeven, as AMD’s diversified AI chip exposure spanning EPYC CPUs, Instinct accelerators, and agentic CPUs captures broad chip-sector enthusiasm. UBS raised Micron Technologies’ (MU) share-price target to $1,625 from $535 citing durable AI-era memory economics, sending sentiment ri...
Quick Read Advanced Micro Devices (AMD) stock rose 5% today, outperforming Intel (INTC) at +2% and NVIDIA (NVDA) at breakeven, as AMD’s diversified AI chip exposure spanning EPYC CPUs, Instinct accelerators, and agentic CPUs captures broad chip-sector enthusiasm. UBS raised Micron Technologies’ (MU) share-price target to $1,625 from $535 citing durable AI-era memory economics, sending sentiment rippling through the semiconductor complex and signaling investor appetite for higher multiples on AI infrastructure beneficiaries like AMD. It sounds nuts, but SoFi is giving new active invest users up to $1,000 in stock for a limited time, and all it takes is a $50 deposit to get started. See for yourself (Sponsor) Shares of Advanced Micro Devices (NASDAQ:AMD) are up 5% in early Tuesday trading, leading a broad lift across the chip complex. Intel (NASDAQ:INTC) is up 2%, while NVIDIA (NASDAQ:NVDA) is essentially flat. The move follows a price target bombshell from UBS on Micron Technology (NASDAQ:MU) this morning. UBS raised its Micron target to $1,625 from $535, citing long-term memory supply agreements and durable AI-era memory economics with EPS above $100 through 2029. That magnitude of rerating is rippling through the semiconductor group. Micron shares are up by more than 10% intraday, and that sentiment is lifting names that compete with or sit adjacent to the memory trade. AMD stock is leading the trio on the day, though the action looks broad-based rather than company-specific. SoFi Active Invest is offering a limited-time promotion. Open an account, fund it with $50 or more, and you could receive up to $1,000 in complimentary stock for Active Invest accounts. See for yourself by clicking here now. Why AMD Leads the Chip Basket Advanced Micro Devices has the most diversified AI chip exposure among the three, spanning EPYC server CPUs, the Instinct accelerator line, and an emerging agentic CPU narrative. That breadth means a sentiment lift across the AI complex tends ...
STORY: Xiaomi posted a 43% slump in first-quarter net profit on Tuesday. The Chinese tech giant's smartphone business was pressured by high memory chip costs. Xiaomi said first-quarter revenue was around $14.6 billion - slightly below analyst forecasts. And it reported an $899 million adjusted net profit for the January to March period - also below market estimates. Industry data showed the world'...
STORY: Xiaomi posted a 43% slump in first-quarter net profit on Tuesday. The Chinese tech giant's smartphone business was pressured by high memory chip costs. Xiaomi said first-quarter revenue was around $14.6 billion - slightly below analyst forecasts. And it reported an $899 million adjusted net profit for the January to March period - also below market estimates. Industry data showed the world's number three smartphone maker shipped 33.8 million smartphone units in the first quarter. That was down close to a fifth from a year ago and the sharpest drop among the top five global brands. Looking ahead, industry experts believe the smartphone market outlook for the year is weak. They project a memory chip crunch may lasting until late 2027 and Middle East tensions also weighing on consumer sentiment. The firm is investing heavily in electric vehicles and AI as it looks for revenue drivers beyond its core handset business. Xiaomi's EV business is growing but still drags on earnings because of heavy investment and lower margins. The company reported roughly $2.8 billion in revenue for its EV business for the first quarter - up more than 5% from a year ago. But the loss from operations related to its EV, AI and other new initiatives reached about $456 million. Xiaomi delivered close to 81,000 EVs in the first quarter - down over 44% from Q4. Although deliveries were up 6.6% from a year earlier.
NEW YORK (AP) — PayPal helped invent online checkout. Nearly three decades later, it’s struggling to defend its turf. The iconic online payments company is facing its biggest challenge in nearly three decades of existence. Its core business of customers using the app to check out when shopping online is barely growing and new management has bluntly warned investors that “significant changes” will ...
NEW YORK (AP) — PayPal helped invent online checkout. Nearly three decades later, it’s struggling to defend its turf. The iconic online payments company is facing its biggest challenge in nearly three decades of existence. Its core business of customers using the app to check out when shopping online is barely growing and new management has bluntly warned investors that “significant changes” will be needed to fix the company’s problems. One of the biggest success stories of the original dot-com era, PayPal has seen its territory steadily conquered by new and existing competitors, particularly Apple, Shopify, the buy now, pay later companies like Affirm and Klarna, and peer-to-peer money transfer services like Cash App and Zelle, particularly in the past five years. As a result, PayPal’s stock has fallen nearly 40% in the past 12 months. The stock, which soared during the pandemic as millions of Americans started shopping online for groceries and other necessities, has plunged roughly 80% in the past five years as investors worried that PayPal missed an opportunity to leverage its name recognition and dominance in online payments and allowed its competitors to take market share that will be hard to recover. Investors’ concerns are not about profitability, although PayPal did warn investors that 2026 profits would be down from the previous year. The concerns lie more with how will PayPal grow and maintain its market with increasing competition. PayPal said in its first-quarter earnings report that branded checkout — the company’s most profitable business by margin — grew just 2%. While the company noted there had been a slowdown in its European division and other discretionary purchases, a growth of only 2% in one of the fastest growing industries alarmed investors and shares dropped nearly 8%. The pressures on PayPal's business have led to some dramatic changes at the top of the company. The board ousted CEO Alex Chriss in February and replaced him with Enrique Lores...
Conference Board Consumer Expectations Hit YTD Highs, Inflation Fears Dip In May With war (and rising gas prices) now fully embedded in respondents' minds (along with record high stock prices), it is perhaps not entirely surprising that The Conference Board's Consumer Confidence dipped in May (but was better than expected) . The headline index dipped 0.7 points to 93.1 in May, down from an upwardl...
Conference Board Consumer Expectations Hit YTD Highs, Inflation Fears Dip In May With war (and rising gas prices) now fully embedded in respondents' minds (along with record high stock prices), it is perhaps not entirely surprising that The Conference Board's Consumer Confidence dipped in May (but was better than expected) . The headline index dipped 0.7 points to 93.1 in May, down from an upwardly revised 93.8 in April. The Present Situation Index - based on consumers’ assessment of current business and labor market conditions - retreated by 3.2 points to 121.2. The Expectations Index - based on consumers’ short-term outlook for income, business, and labor market conditions - rose by 1.0 points to 74.4 - the highest since Dec 2025. Source: Bloomberg “Consumer confidence edged downward in May as the inflationary impacts of the war in the Middle East intensified,” said Dana M Peterson, Chief Economist, The Conference Board. “Consumer appraisals of current business conditions and the current labor market were moderately less positive compared to last month. This was somewhat offset by modest improvements in consumers’ expectations for business conditions and the labor market six months from now. Meanwhile, income expectations eased in May, as those anticipating less income rose.” Consumers’ average and median 12-month inflation expectations ticked downward but remained elevated. The overall trend of the labor market remains weaker... Among age groups, confidence ticked up for consumers aged 35-54, but trended downward for older and younger consumers, both month-over-month and on a six-month moving average basis. By income, confidence among higher income groups trended upward on a six-month moving average basis. By generation, confidence improved for the Silent Generation (the oldest group) but was little changed or lower among other generations. By political affiliation, Republicans remained the most optimistic, while Independents were the only group that saw confiden...
When the US and Iranian attacks started and internet access was cut off, Iran had only enjoyed full access to the outside world for only about a month following a previous shutdown imposed during January's deadly regime crackdown on anti-government protests.
When the US and Iranian attacks started and internet access was cut off, Iran had only enjoyed full access to the outside world for only about a month following a previous shutdown imposed during January's deadly regime crackdown on anti-government protests.
00:00 Speaker A So here we have a pretty broad rally in chips, but one of these stands out, and that is Micron. Micron shares are up 14% today and that brings the total for the year to almost 200%. What is the catalyst for Micron in particular today? Well, they got a price target boost over at UBS here. You ready for this? 00:20 Speaker A The price target had been $535 from Timothy Arcuri over the...
00:00 Speaker A So here we have a pretty broad rally in chips, but one of these stands out, and that is Micron. Micron shares are up 14% today and that brings the total for the year to almost 200%. What is the catalyst for Micron in particular today? Well, they got a price target boost over at UBS here. You ready for this? 00:20 Speaker A The price target had been $535 from Timothy Arcuri over there. Now it's 1625, 1,625. You see the stock is trading around 855 today. So that leaves a lot of room for upside. 00:40 Speaker A And basically, Arcuri is looking at the structural changes that we have seen in demand for DRAM, which is one of the types of memory and more specifically, of course, the high bandwidth memory that is key to the AI build out that has really lit a fire under this company's earnings and under the stock. 01:00 Speaker A And the structural change is that we have now gone to more long-term agreements for these types of chips. Long-term agreements is not something that was characteristic of the memory space in the past. It was more short-term. Now we're talking about that there's several years in terms of of some of these, um, these agreements. 01:20 Speaker A And basically, the analyst says that up to 30% of volumes industrywide will be soon locked in at pricing that is just slightly below current levels, and these agreements will allow Micron to trade some near-term revenue for demand visibility and a smoother earnings profile. 01:36 Speaker A What's also also industry interesting when Arcuri sort of digs into that 1625 price target that he's put on this here, he says this is based on a 15 times near-term P E multiple. He says, we see no reason why Micron should trade a whole lot differently than Nvidia in terms of PE. 01:56 Speaker A So, thought that was an interesting statement as well. And again, these shares are up another 14% today, and we see lifts in other parts of the memory and storage complex today as a result.
00:00 Speaker A So here we have a pretty broad rally in chips, but one of these stands out, and that is Micron. Micron shares are up 14% today and that brings the total for the year to almost 200%. What is the catalyst for Micron in particular today? Well, they got a price target boost over at UBS here. You ready for this? 00:20 Speaker A The price target had been $535 from Timothy Arcuri over the...
00:00 Speaker A So here we have a pretty broad rally in chips, but one of these stands out, and that is Micron. Micron shares are up 14% today and that brings the total for the year to almost 200%. What is the catalyst for Micron in particular today? Well, they got a price target boost over at UBS here. You ready for this? 00:20 Speaker A The price target had been $535 from Timothy Arcuri over there. Now it's 1625, 1,625. You see the stock is trading around 855 today. So that leaves a lot of room for upside. 00:40 Speaker A And basically, Arcuri is looking at the structural changes that we have seen in demand for DRAM, which is one of the types of memory and more specifically, of course, the high bandwidth memory that is key to the AI build out that has really lit a fire under this company's earnings and under the stock. 01:00 Speaker A And the structural change is that we have now gone to more long-term agreements for these types of chips. Long-term agreements is not something that was characteristic of the memory space in the past. It was more short-term. Now we're talking about that there's several years in terms of of some of these, um, these agreements. 01:20 Speaker A And basically, the analyst says that up to 30% of volumes industrywide will be soon locked in at pricing that is just slightly below current levels, and these agreements will allow Micron to trade some near-term revenue for demand visibility and a smoother earnings profile. 01:36 Speaker A What's also also industry interesting when Arcuri sort of digs into that 1625 price target that he's put on this here, he says this is based on a 15 times near-term P E multiple. He says, we see no reason why Micron should trade a whole lot differently than Nvidia in terms of PE. 01:56 Speaker A So, thought that was an interesting statement as well. And again, these shares are up another 14% today, and we see lifts in other parts of the memory and storage complex today as a result.
Huawei is rewriting the semiconductor rulebook. On Monday, May 25, the Chinese tech giant unveiled a new Huawei chip architecture that sidesteps the foundational assumptions behind U.S. export restrictions. For investors in AI hardware, this development deserves careful attention. What Huawei Actually Proposed He Tingbo, chair of Huawei's Scientist Committee, delivered the announcement at the 2026...
Huawei is rewriting the semiconductor rulebook. On Monday, May 25, the Chinese tech giant unveiled a new Huawei chip architecture that sidesteps the foundational assumptions behind U.S. export restrictions. For investors in AI hardware, this development deserves careful attention. What Huawei Actually Proposed He Tingbo, chair of Huawei's Scientist Committee, delivered the announcement at the 2026 IEEE International Symposium on Circuits and Systems in Shanghai. She introduced the Tau Scaling Law, which replaces traditional geometric miniaturization of transistors with time scaling. Peers have already dubbed it “Her's Law.” Huawei expects its chips, based on the new scaling law, to achieve transistor density equivalent to 1.4nm process nodes by 2031. Furthermore, Kirin chips scheduled to launch in late 2026 will be the first to use LogicFolding. The company has not been experimenting blindly. According to He Tingbo, Huawei already used the Tau Scaling Law to design and mass produce 381 chips over the past six years. China's Export Surge Tells the Bigger Story Huawei's architectural breakthrough is not happening in isolation. It reflects a broader and already measurable shift in China's semiconductor output. According to South China Morning Post, citing Chinese customs data, China's integrated circuit exports reached 349.5 billion units in 2025. Total export value climbed 26.8% year over year to $201.9 billion. Volume rose 17.4% over the same period. Why This Matters Beyond the Headlines The Nvidia Problem That concern is already playing out at the software layer. DeepSeek's latest model included support for China-native chips and Huawei's CANN platform. CANN is also open source, which accelerates its adoption in China and elsewhere. Moreover, if the most capable Chinese AI lab demonstrates that competitive models can be built without Nvidia, the argument for maintaining export controls weakens alongside the argument for buying Nvidia. However, software adoption rema...
Torsten Asmus As earnings season winds down, investors are shifting focus to updated quant ratings following the latest wave of corporate results. The scores offer a snapshot of how companies rank across key factors such as valuation, growth, profitability, momentum, and estimate revisions immediately after reporting their quarterly performance. Of note, the Health Care Select Sector SPDR Fund ETF...
Torsten Asmus As earnings season winds down, investors are shifting focus to updated quant ratings following the latest wave of corporate results. The scores offer a snapshot of how companies rank across key factors such as valuation, growth, profitability, momentum, and estimate revisions immediately after reporting their quarterly performance. Of note, the Health Care Select Sector SPDR Fund ETF ( XLV ), which represents a sector holding a substantial 12.12% weight in the S&P 500, has emerged as a distinct laggard in the current market environment. Year-to-date, the XLV has declined 3.17%, starkly underperforming against the 9.17% gain seen in the broader S&P 500 benchmark index. To evaluate individual opportunities within this lagging sector, Seeking Alpha’s Quant system rates stocks on a scale from 1 to 5. Under this model, scores of 3.5 or above are classified as bullish, while scores of 2.5 or below indicate a bearish assessment. Post-earnings quant scorecard: Below is a summary of mid-cap healthcare companies with market capitalizations between $2B and $10B ranked by their current factor scores. Top-quant rated stocks: PACS Group ( PACS ), Quant Rating: 4.80 , Strong Buy. Indivior Pharmaceuticals ( INDV ), Quant Rating: 4.77 , Strong Buy. Relay Therapeutics ( RLAY ), Quant Rating: 4.73 , Strong Buy. Dianthus Therapeutics ( DNTH ), Quant Rating: 4.72 , Strong Buy. Guardian Pharmacy Services ( GRDN ), Quant Rating: 4.56 , Strong Buy. Bottom-quant rated stocks: Doximity ( DOCS ), Quant Rating: 1.11 , Strong Sell. TransMedics Group ( TMDX ), Quant Rating: 1.11 , Strong Sell. Zai Lab Limited ( ZLAB ), Quant Rating: 1.24 , Strong Sell. Prestige Consumer Healthcare ( PBH ), Quant Rating: 1.28 , Strong Sell. RadNet ( RDNT ), Quant Rating: 1.32 , Strong Sell. More on healthcare stocks after earnings season TransMedics: Despite Earnings Miss, Growth Story Remains Intact Relay Therapeutics, Inc. (RLAY) Presents at ISSVA World Congress 2026: The Latest in Vascular Anomal...
chokchaipoomichaiya/iStock via Getty Images Investment Thesis I am upgrading Arqit Quantum Inc. ( ARQQ ) to a Buy, from my Sell back in December . For those of you who've followed my Quantum coverage long enough, you'd notice I've been bearish on this name since January of last year. I maintained that view through five updates, with the stock in the red since four out of five of them, with the exc...
chokchaipoomichaiya/iStock via Getty Images Investment Thesis I am upgrading Arqit Quantum Inc. ( ARQQ ) to a Buy, from my Sell back in December . For those of you who've followed my Quantum coverage long enough, you'd notice I've been bearish on this name since January of last year. I maintained that view through five updates, with the stock in the red since four out of five of them, with the exception being a 2% gain since my March article during a period when the S&P 500 ( SP500 ) gained 32%. The most recent one was in December as I previously mentioned, when the stock was at $28. I said the company hadn't earned the benefit of the doubt after FY2025 revenue missed consensus and guidance for FY2026 failed to impress against a higher monthly cash burn. That call worked, too, with the stock down close to 38% since then, while the S&P 500 was up around 8.5% during the same period. The Techie In December, I said that the trigger that would make me reconsider was tangible proof of scale through a cocktail of accelerating contract wins, improving revenue visibility, and a clear reduction in cash burn relative to growth. The H1 FY26 print delivered the first two cleanly, missed on the third, and Sparkle's commercial launch of Quantum-Safe Interconnect across 20 Equinix ( EQIX ) data centers globally is the closest thing to the Tier-1 reference I have been waiting for. So, what is making me reconsider the opportunity in Arqit is two factors: I think Arqit's fundamentals and timeline are better, although a lot of work remains, and Quantum is making a visible comeback as a peer group, and this time around, it's not all hype, with government involvement. Stock performance: To understand the setup, you have to understand that Arqit has lagged badly behind the rest of the quantum sector. The stock is down 20% year-to-date. Over that same window, IonQ ( IONQ ) is up over 40%, Quantum Computing ( QUBT ) and Rigetti ( RGTI ) are up about 20% each, and D-Wave ( QBTS ) is up about...
The S&P 500 Index ($SPX) (SPY) today is up +0.72%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.31%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.42%. June E-mini S&P futures (ESM26) are up +0.62%, and June E-mini Nasdaq futures (NQM26) are up +1.33%. Stock indexes are rallying today, with the S&P 500 and Nasdaq 100 posting new all-time highs. Stocks are finding support today from a ...
The S&P 500 Index ($SPX) (SPY) today is up +0.72%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.31%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.42%. June E-mini S&P futures (ESM26) are up +0.62%, and June E-mini Nasdaq futures (NQM26) are up +1.33%. Stock indexes are rallying today, with the S&P 500 and Nasdaq 100 posting new all-time highs. Stocks are finding support today from a drop in crude oil prices and bond yields after officials signaled the US was nearing a deal with Iran to reopen the Strait of Hormuz and restore oil flows. According to the Washington Post, the US and Iran have developed a memorandum that would extend the ceasefire by 60 days as the two sides seek a permanent deal, and if agreed, the Strait of Hormuz would be de-mined and reopened in the meantime. Secretary of State Rubio said negotiations will still "take a few days" as both sides discuss language in an initial document. WTI crude oil fell to a 2.5-week low today, and the 10-year T-note yield fell to a 1.5-week low of 4.47%. However, stock index futures were undercut after the US Central Command said US forces struck Iranian missile-launch sites and boats trying to place mines in the Strait of Hormuz. US economic news today was mixed for stocks. The Apr Chicago Fed National Activity Index rose +0.29 to a 13-month high of 0.14, stronger than expectations of -0.03. Also, the Mar S&P Composite-20 home price index rose +0.83% y/y, a smaller increase than the +0.90% y/y expected and the smallest year-on-year gain in more than 2.5 years. WTI crude oil prices (CLM26) remain extremely volatile and are susceptible to headlines from the Iran war. Crude oil prices fell more than -3% today at a 2.5-week low after the US and Iran said peace talks were progressing. However, crude prices rebounded from their worst levels after US and Israeli jets struck missile sites in Iran and boats laying mines in the Strait of Hormuz. The International Energy Agency (IEA) said in a recently released ...
Hemab Therapeutics will likely see more upside in the wake of its recent public listing due to its progress toward developing the first treatment for a pair of rare bleeding disorders, according to Goldman Sachs. The investment bank, which was one of the company's IPO underwriters, initiated coverage of the biotechnology name with a buy rating. It also put a $36 price target on shares, implying 39...
Hemab Therapeutics will likely see more upside in the wake of its recent public listing due to its progress toward developing the first treatment for a pair of rare bleeding disorders, according to Goldman Sachs. The investment bank, which was one of the company's IPO underwriters, initiated coverage of the biotechnology name with a buy rating. It also put a $36 price target on shares, implying 39% upside from Friday's close. "Our Buy rating is driven by sutacimig's potential to dominate [a few rare bleeding disorder therapy] markets as the solo treatment option and HMB-002 having … potential in a large [Von Willebrand disease] market," analyst Richard Law said Tuesday in a note to clients. Hemab went public on May 4, pricing its IPO at $18. The stock doubled that day, hitting a high of $36.61. Since then, it has traded within a $23 to $29 range. On Tuesday, it popped 7% to around $27.75 as Goldman and other Wall Street shops assigned bullish ratings on shares. One-of-a-kind therapy Hemab aims to treat Glanzmann's thrombasthenia and Factor VII deficiency, two very rare inherited bleeding conditions that inhibit blood clotting, with its trial-stage therapy called sutacimig, according to Law. There are currently no other treatments being developed to treat GT and FVIID, meaning Hemab can aim to entirely capture both markets with sutacimig. And while only about 1,000 patients with either of the two disorders live in the U.S., countries in the Gulf Corporation Council have up to roughly five-times as many constituents suffering from the disorders, per the bank. In an early phase trial of sutacimig, use of the drug led to annualized treated bleeding rate reductions across all dosing regimens studied, without regard to the source and cause of bleeding. Hemab is also working on a therapy called HMB-002 to treat Von Willebrand disease, a more common bleeding disorder — which Goldman thinks could further boost shares.
Elbit Systems (NASDAQ:ESLT) reported a stronger first quarter of 2026, with management highlighting double-digit growth in revenue, operating profit and earnings per share, as well as a record backlog that surpassed $30 billion for the first time. Kobi Kagan, the company’s chief financial officer, said first-quarter revenue rose 15.5% to $2.189 billion, compared with $1.896 billion in the first qu...
Elbit Systems (NASDAQ:ESLT) reported a stronger first quarter of 2026, with management highlighting double-digit growth in revenue, operating profit and earnings per share, as well as a record backlog that surpassed $30 billion for the first time. Kobi Kagan, the company’s chief financial officer, said first-quarter revenue rose 15.5% to $2.189 billion, compared with $1.896 billion in the first quarter of 2025. He said the quarter’s revenue also exceeded the preceding fourth quarter, reflecting “the strong demand we are witnessing from our key markets.” GAAP operating income increased to $205.1 million, or 9.4% of revenue, from $149.7 million, or 7.9% of revenue, a year earlier. On a non-GAAP basis, operating income was $222 million, or 10.1% of revenue, compared with $165.1 million, or 8.7% of revenue, in the prior-year period. GAAP diluted earnings per share rose 42% to $3.34 from $2.35, while non-GAAP diluted EPS increased 51% to $3.87 from $2.57. Kagan said gross margins expanded due to scale and product mix, with GAAP gross margin rising to 25.2% from 24.0% a year earlier. Backlog tops $30 billion Elbit’s backlog reached $30.2 billion as of March 31, 2026, up by more than $7 billion from the end of March 2025. Kagan said approximately 71% of the backlog was generated outside Israel. About 49% of the backlog is scheduled to be performed during the remainder of 2026 and in 2027, with the rest scheduled for 2028 and beyond. The increase in backlog during the quarter came mainly from Israel, Kagan said. President and Chief Executive Officer Bezhalel Machlis said contract awards during the quarter totaled more than $4 billion, nearly double quarterly revenue. Machlis also highlighted a contract announced the morning of the call, valued at approximately $1.4 billion, from a European customer for military modernization programs. He said the five-year contract includes uncrewed autonomous systems, networked land electronic warfare, precision-guided munitions, artillery...